Abstract
In the last three decades, an increasing number of pathogens resistant to common antibiotics have been a serious threat to public health worldwide. Pleuromutilin, its derivatives and others natural products are important in the fight against pathogen resistant to common antibiotics, such as in respiratory diseases. The aim of the current review is to highlight the most important pleuromutilin derivatives described in the literature between the years of 2007 and 2009.
Keywords: Natural products, drugs, pleuromutilin, respiratory diseases
Current Respiratory Medicine Reviews
Title: Recent Developments in Pleuromutilin Derivatives: A Promising Class Against Bacterial Respiratory Disease
Volume: 6 Issue: 2
Author(s): Raoni Schroeder Borges Goncalves and Marcus Vinicius Nora de Souza
Affiliation:
Keywords: Natural products, drugs, pleuromutilin, respiratory diseases
Abstract: In the last three decades, an increasing number of pathogens resistant to common antibiotics have been a serious threat to public health worldwide. Pleuromutilin, its derivatives and others natural products are important in the fight against pathogen resistant to common antibiotics, such as in respiratory diseases. The aim of the current review is to highlight the most important pleuromutilin derivatives described in the literature between the years of 2007 and 2009.
Export Options
About this article
Cite this article as:
Schroeder Borges Goncalves Raoni and Vinicius Nora de Souza Marcus, Recent Developments in Pleuromutilin Derivatives: A Promising Class Against Bacterial Respiratory Disease, Current Respiratory Medicine Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339810791171287
DOI https://dx.doi.org/10.2174/157339810791171287 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Integrins: Regulators of Tissue Function and Cancer Progression
Current Pharmaceutical Design Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Current Medicinal Chemistry Transcriptionally Targeted Adenovirus Vectors
Current Gene Therapy First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?
Current Gene Therapy Vaccines and Vaccine Strategies Against HIV
Current Drug Targets Does Phosphodiesterase 11A (PDE11A) Hold Promise as a Future Therapeutic Target?
Current Pharmaceutical Design Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders
Current Drug Targets - Infectious Disorders Targeting DNA Minor Groove by Hybrid Molecules as Anticancer Agents
Current Medicinal Chemistry Antioxidant, Pro-Oxidant and Other Biological Activities of Sesquiterpenes
Current Topics in Medicinal Chemistry Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease
Current Medicinal Chemistry Radiopharmaceuticals in Tumor Hypoxia Imaging: A Review Focused on Medicinal Chemistry Aspects
Anti-Cancer Agents in Medicinal Chemistry Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Current Pharmaceutical Design Neural Differentiation and Therapeutic Potential of Adipose Tissue Derived Stem Cells
Current Stem Cell Research & Therapy Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry Recent Patents Therapeutic Agents for Cancer
Recent Patents on Anti-Cancer Drug Discovery DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis
Current Pharmaceutical Design Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
Current Cancer Drug Targets The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies
Current Pharmaceutical Design HIV-1 Integrase Inhibition: Binding Sites, Structure Activity Relationships and Future Perspectives
Current Medicinal Chemistry